Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,081 | 819 | 99.9% |
| Education | $9.41 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,357 | 118 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,815 | 254 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,339 | 113 | $0 (2024) |
| GENZYME CORPORATION | $582.65 | 48 | $0 (2024) |
| Grifols USA, LLC | $452.42 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $438.31 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $373.66 | 33 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $276.09 | 27 | $0 (2021) |
| Amgen Inc. | $263.91 | 16 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $203.73 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,370 | 78 | AstraZeneca Pharmaceuticals LP ($336.94) |
| 2023 | $2,197 | 135 | AstraZeneca Pharmaceuticals LP ($480.17) |
| 2022 | $1,945 | 147 | AstraZeneca Pharmaceuticals LP ($546.65) |
| 2021 | $1,551 | 110 | AstraZeneca Pharmaceuticals LP ($522.17) |
| 2020 | $1,401 | 99 | AstraZeneca Pharmaceuticals LP ($511.33) |
| 2019 | $1,504 | 96 | GlaxoSmithKline, LLC. ($518.68) |
| 2018 | $1,080 | 79 | GlaxoSmithKline, LLC. ($410.36) |
| 2017 | $1,044 | 76 | GlaxoSmithKline, LLC. ($239.77) |
All Payment Transactions
820 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 08/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $8.45 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 08/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: HFCWO | ||||||
| 08/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Immunology | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Immunology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiology | ||||||
| 07/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $26.17 | General |
| Category: Medical Device | ||||||
| 06/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,161 | 1,333 | $166,932 | $59,818 |
| 2022 | 10 | 1,407 | 1,591 | $197,841 | $70,916 |
| 2021 | 8 | 1,576 | 1,773 | $233,129 | $87,942 |
| 2020 | 11 | 1,372 | 1,609 | $225,086 | $72,001 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 319 | 426 | $67,308 | $26,716 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 210 | $49,350 | $18,660 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $20,577 | $6,221 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $7,080 | $2,213 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,804 | $1,322 | 34.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 114 | 117 | $3,627 | $1,041 | 28.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 112 | 115 | $4,370 | $878.49 | 20.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 113 | 116 | $2,668 | $768.45 | 28.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 79 | 79 | $2,449 | $693.12 | 28.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 78 | 78 | $2,964 | $586.50 | 19.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 79 | 79 | $1,817 | $515.28 | 28.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 13 | 14 | $918.00 | $203.65 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 344 | 457 | $72,206 | $28,550 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 228 | $53,580 | $20,540 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $26,353 | $8,343 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $11,800 | $3,402 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $5,902 | $2,162 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $4,438 | $1,983 | 44.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 143 | 147 | $4,557 | $1,350 | 29.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 142 | 146 | $5,548 | $1,149 | 20.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 143 | 147 | $3,381 | $1,005 | 29.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 102 | 102 | $3,162 | $873.45 | 27.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 101 | 101 | $3,838 | $749.59 | 19.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 102 | 102 | $2,346 | $650.12 | 27.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 11 | 11 | $730.00 | $159.38 | 21.8% |
About Dr. Michael Halvonik, MD
Dr. Michael Halvonik, MD is a Critical Care Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538249404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Halvonik, MD has received a total of $12,090 in payments from pharmaceutical and medical device companies, with $1,370 received in 2024. These payments were reported across 820 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($12,081).
As a Medicare-enrolled provider, Halvonik has provided services to 5,516 Medicare beneficiaries, totaling 6,306 services with total Medicare billing of $290,677. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Cincinnati, OH
- Active Since 10/16/2006
- Last Updated 11/26/2014
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1538249404
Products in Payments
- NUCALA (Biological) $1,087
- TRELEGY ELLIPTA (Drug) $1,026
- DUPIXENT (Biological) $956.31
- TEZSPIRE (Biological) $722.88
- OFEV (Drug) $675.92
- FARXIGA (Drug) $674.21
- SYMBICORT (Drug) $673.59
- SPIRIVA RESPIMAT (Drug) $436.53
- Prolastin-C Liquid (Biological) $418.56
- GLASSIA (Biological) $414.50
- BREZTRI (Drug) $329.78
- FASENRA (Biological) $291.31
- ANORO (Drug) $277.68
- BREZTRI AEROSPHERE (Drug) $259.10
- BREO (Drug) $216.04
- FASENRA (Drug) $189.49
- CUVITRU (Biological) $188.41
- STIOLTO RESPIMAT (Drug) $179.14
- OPSUMIT MACITENTAN (Drug) $169.09
- SMARTVEST (Device) $151.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Cincinnati
Brandon Foreman, Md Ms, MD MS
Critical Care Medicine — Payments: $401,928
Mohammad Sheatt, Md, MD
Critical Care Medicine — Payments: $363,450
Joseph Thorpe, Md, MD
Critical Care Medicine — Payments: $22,853
Craig Eisentrout, Md, MD
Critical Care Medicine — Payments: $17,559
Dr. Ramakanth Pata, M.d, M.D
Critical Care Medicine — Payments: $7,365
Dr. Sunil Dama, M.d, M.D
Critical Care Medicine — Payments: $6,747